Plerixafor

Details

Files
Generic Name:
Plerixafor
Project Status:
Complete
Therapeutic Area:
Hematopoietic stem cell mobilizer in non-Hodgkin's lymphoma and multiple myeloma
Manufacturer:
Genzyme Canada Inc.
Call for patient/clinician input open:
Brand Name:
Mozobil
Project Line:
Reimbursement Review
Project Number:
SR0265-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Submission Type:
Initial
Indications:
Hematopoietic stem cell mobilizer in non-Hodgkin's lymphoma and multiple myeloma
Recommendation Type:
Do not list
Final Recommendation: